Stock listing
Frankfurt:AAJ0 Perspective Therapeutics, Inc. Aktie
German listing (Frankfurt) of Perspective Therapeutics, Inc. · home listing NYSE American:CATX
Follow Perspective Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · AMEX:CATX
$1.04 USD -0.11 (-9.6%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, AMEX:CATX
- Day range
- $1.03 – $1.19 USDNov 2, 2026
- Volume
- 2.10M sharesNov 2, 2026
- Market cap
- $118.7M USDAt the close on Nov 2, 2026 · price × 114.2M shares outstanding
- 52-week range
- $1.03 – $6.16 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $4.89M USDMedian day 1.47M shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:CATX · Home | $1.04 USD | -0.11 (-9.6%) | 2,098,258 | $1.15 | $1.185 | $1.03 | $1.15 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · AMEX:CATX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.04 | -0.11 | -9.6% | $1.15 | $1.185 | $1.03 | 2,098,258 | |
| $1.15 | -0.02 | -1.7% | $1.12 | $1.15 | $1.09 | 2,309,335 | |
| $1.17 | -0.08 | -6.4% | $1.25 | $1.275 | $1.15 | 2,215,827 | |
| $1.25 | +0.06 | +5.0% | $1.21 | $1.25 | $1.065 | 4,593,438 | |
| $1.19 | -0.02 | -1.7% | $1.20 | $1.26 | $1.06 | 8,739,478 | |
| $1.21 | -0.40 | -24.8% | $1.40 | $1.591 | $1.115 | 9,622,962 | |
| $1.61 | -0.65 | -28.8% | $2.40 | $2.40 | $1.58 | 5,613,965 | |
| $2.26 | -0.04 | -1.7% | $2.25 | $2.335 | $2.22 | 967,762 | |
| $2.30 | 0.00 | 0.0% | $2.32 | $2.365 | $2.275 | 1,241,268 | |
| $2.30 | +0.11 | +5.0% | $2.19 | $2.37 | $2.19 | 1,812,751 | |
| $2.19 | +0.02 | +0.9% | $2.20 | $2.249 | $2.15 | 1,138,613 | |
| $2.17 | -0.17 | -7.3% | $2.34 | $2.34 | $2.15 | 1,669,659 | |
| $2.34 | +0.10 | +4.5% | $2.27 | $2.37 | $2.23 | 1,189,876 | |
| $2.24 | -0.03 | -1.3% | $2.36 | $2.36 | $2.21 | 1,394,498 | |
| $2.27 | -0.25 | -9.9% | $2.50 | $2.52 | $2.25 | 1,309,910 | |
| $2.52 | -0.14 | -5.3% | $2.61 | $2.67 | $2.505 | 640,582 | |
| $2.66 | -0.05 | -1.8% | $2.71 | $2.755 | $2.625 | 1,104,732 | |
| $2.71 | +0.25 | +10.2% | $2.43 | $2.73 | $2.37 | 3,255,036 | |
| $2.46 | +0.10 | +4.2% | $2.37 | $2.51 | $2.322 | 1,285,777 | |
| $2.36 | -0.21 | -8.2% | $2.59 | $2.60 | $2.30 | 2,702,852 | |
| $2.57 | -0.19 | -6.9% | $2.75 | $2.82 | $2.48 | 3,560,749 | |
| $2.76 | +0.04 | +1.5% | $2.77 | $2.82 | $2.685 | 2,622,136 | |
| $2.72 | -0.03 | -1.1% | $2.71 | $2.775 | $2.66 | 1,542,531 | |
| $2.75 | +0.13 | +5.0% | $2.64 | $2.775 | $2.55 | 1,670,313 | |
| $2.62 | +0.12 | +4.8% | $2.52 | $2.62 | $2.49 | 1,542,351 | |
| $2.50 | -0.02 | -0.8% | $2.50 | $2.575 | $2.46 | 1,504,853 | |
| $2.52 | +0.02 | +0.8% | $2.50 | $2.525 | $2.45 | 1,801,824 | |
| $2.50 | -0.12 | -4.6% | $2.58 | $2.59 | $2.44 | 1,698,409 | |
| $2.62 | -0.34 | -11.5% | $2.89 | $2.92 | $2.50 | 3,161,056 | |
| $2.96 | -0.01 | -0.3% | $3.00 | $3.02 | $2.814 | 5,145,236 | |
| $2.97 | +0.09 | +3.1% | $2.94 | $3.03 | $2.895 | 2,111,840 | |
| $2.88 | 0.00 | 0.0% | $2.89 | $2.94 | $2.77 | 11,636,161 | |
| $2.88 | +0.18 | +6.7% | $2.76 | $2.92 | $2.74 | 1,168,195 | |
| $2.70 | -0.03 | -1.1% | $2.73 | $2.75 | $2.62 | 1,582,357 | |
| $2.73 | -0.19 | -6.5% | $2.88 | $2.89 | $2.66 | 1,474,352 | |
| $2.92 | +0.11 | +3.9% | $2.81 | $2.96 | $2.79 | 2,024,407 | |
| $2.81 | +0.04 | +1.4% | $2.77 | $2.825 | $2.665 | 2,024,744 | |
| $2.77 | -0.22 | -7.4% | $2.96 | $3.01 | $2.75 | 1,582,652 | |
| $2.99 | -0.13 | -4.2% | $3.07 | $3.108 | $2.96 | 1,499,216 | |
| $3.12 | -0.01 | -0.3% | $3.12 | $3.18 | $3.02 | 1,061,381 | |
| $3.13 | +0.01 | +0.3% | $3.07 | $3.18 | $3.025 | 1,365,189 | |
| $3.12 | +0.02 | +0.6% | $3.09 | $3.14 | $3.03 | 931,703 | |
| $3.10 | 0.00 | 0.0% | $3.10 | $3.235 | $3.025 | 864,638 | |
| $3.10 | -0.06 | -1.9% | $3.16 | $3.165 | $3.07 | 705,838 | |
| $3.16 | +0.05 | +1.6% | $3.11 | $3.18 | $3.08 | 910,730 | |
| $3.11 | -0.07 | -2.2% | $3.16 | $3.17 | $3.075 | 913,335 | |
| $3.18 | +0.02 | +0.6% | $3.15 | $3.24 | $3.10 | 797,531 | |
| $3.16 | -0.13 | -4.0% | $3.28 | $3.30 | $3.14 | 799,217 | |
| $3.29 | +0.10 | +3.1% | $3.22 | $3.325 | $3.20 | 773,771 | |
| $3.19 | -0.11 | -3.3% | $3.32 | $3.37 | $3.13 | 678,656 | |
| $3.30 | +0.09 | +2.8% | $3.25 | $3.44 | $3.22 | 1,135,300 | |
| $3.21 | -0.27 | -7.8% | $3.46 | $3.56 | $3.18 | 1,180,700 | |
| $3.48 | +0.27 | +8.4% | $3.31 | $3.50 | $3.30 | 1,751,700 | |
| $3.21 | -0.01 | -0.3% | $3.21 | $3.25 | $3.13 | 757,900 | |
| $3.22 | +0.02 | +0.6% | $3.21 | $3.31 | $3.19 | 1,168,200 | |
| $3.20 | +0.10 | +3.2% | $3.09 | $3.23 | $3.03 | 1,000,200 | |
| $3.10 | -0.16 | -4.9% | $3.26 | $3.28 | $3.09 | 1,318,600 | |
| $3.26 | +0.08 | +2.5% | $3.18 | $3.28 | $3.105 | 1,185,900 | |
| $3.18 | +0.18 | +6.0% | $3.05 | $3.245 | $2.994 | 1,803,759 | |
| $3.00 | 0.00 | 0.0% | $3.00 | $3.055 | $2.935 | 915,894 | |
| $3.00 | +0.03 | +1.0% | $3.03 | $3.06 | $2.94 | 1,045,838 | |
| $2.97 | +0.03 | +1.0% | $2.97 | $3.06 | $2.94 | 503,364 | |
| $2.94 | -0.06 | -2.0% | $3.00 | $3.16 | $2.92 | 1,705,763 | |
| $3.00 | -0.01 | -0.3% | $3.01 | $3.12 | $2.98 | 2,292,441 | |
| $3.01 | +0.10 | +3.4% | $2.92 | $3.03 | $2.86 | 871,968 |
- Ticker
- Frankfurt:AAJ0
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 23, 2026
Perspective’s [212Pb]Bamzireotide Navoxetan (VMT-α-NET) Demonstrates Encouraging Safety, Durable Disease Control, and Robust Tumor Response Across Multiple Dose Cohorts in Phase 1/2a Trial in Advanced SSTR2-Expressing NETs
Latest deck · Oct 23, 2026
ESMO 2026
Conference · 25 slides
Latest news
Perspective’s [212Pb]Bamzireotide Navoxetan (VMT-α-NET) Demonstrates Encouraging Safety, Durable Disease Control, and Robust Tumor Response Across Multiple Dose Cohorts in Phase 1/2a Trial in Advanced SSTR2-Expressing NETs
Oct 23, 2026
Closed $1.61 (-28.8%) on Oct 23, 2026
Perspective Therapeutics Announces Clinical Collaboration and Supply Agreement with Merck to Evaluate [212Pb]PSV359 in Combination with Keytruda® (Pembrolizumab) in FAP-α Positive Solid Tumors
Sep 14, 2026
Closed $2.92 (+3.9%) on Sep 14, 2026
Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2026 Financial Results
Jul 31, 2026
Closed $2.91 (-2.7%) on Jul 31, 2026
Perspective Therapeutics Receives European Orphan Medicinal Product Designation for [212Pb]VMT-α-NET in GEP-NETs
Jul 28, 2026
Closed $2.87 (+1.8%) on Jul 28, 2026
Perspective Therapeutics Expands Therapeutic Focus Areas; First Patient Dosed with [212Pb]VMT-α-NET in the Meningioma Cohort of a Phase 1/2a Study
Jun 3, 2026
Closed $3.56 (-1.1%) on Jun 3, 2026
Perspective Therapeutics Announces First Patients Dosed in New Cohorts of Two Ongoing Phase 1/2a Studies
May 18, 2026
Closed $3.76 (-2.3%) on May 18, 2026
Perspective Therapeutics to Provide Several Upcoming Corporate Updates
Apr 24, 2026
Closed $4.51 (0.0%) on Apr 24, 2026
Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in Its Ongoing Phase 1/2a Clinical Trial at the 2026 AACR Annual Meeting
Apr 20, 2026
Closed $4.55 (+8.3%) on Apr 20, 2026
Perspective Therapeutics to Participate in Upcoming Investor Conferences
Apr 2, 2026
Closed $4.41 (-0.2%) on Apr 2, 2026
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the AACR Annual Meeting 2026
Mar 17, 2026
Closed $4.86 (-1.8%) on Mar 18, 2026
Decks
ESMO 2026
Conference · 25 slides · Oct 23, 2026
Investor Presentation (October 2026)
Investor deck · 87 slides · Oct 1, 2026
Investor Presentation (September 2026)
Investor deck · 77 slides · Sep 8, 2026
Investor Presentation (July 2026)
Investor deck · 60 slides · Jul 1, 2026
Perspective Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 19 in the last 12 months · 36 in all · newest Oct 23, 2026 · oldest 2025
- Decks
- 38 decks · latest Oct 23, 2026
Where Perspective Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:CATX · Home listing | NYSE American | United States | USD |
| gettex:AAJ0 | gettex | Germany | EUR |
| BOATS:CATX | BOATS | United States | USD |
| LS Exchange:A40EDR | LS Exchange | Germany | EUR |
| Lang & Schwarz:A40EDR | Lang & Schwarz | Germany | EUR |
| Dusseldorf:AAJ0 | Dusseldorf | Germany | EUR |
| Munich:AAJ0 | Munich | Germany | EUR |
| Stuttgart:AAJ0 | Stuttgart | Germany | EUR |
| Tradegate:AAJ0 | Tradegate | Germany | EUR |
| Frankfurt:AAJ0 · This page | Frankfurt | Germany | EUR |
Log in to ask 6ix AI your own questions about Perspective Therapeutics, Inc.